Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/9/2020
SIETES contiene 93097 citas

 
 
<< anterior 41 a 60 de 343 siguiente >>
Presentar resultados
Seleccionar todas
41. Cita con resumen
Anónimo. Métoclopramide: dyskinésies tardives. Prescrire 2009;29:432. [Ref.ID 86019]
42.Tiene citas relacionadas Cita con resumen
Clewley JP, Kelly CM, Andrews N, Vogliqi K, Mallinson G, Kaisar M, Hilton DA, Ironside JW, Edwards P, McCardle LM, Ritchie DL, Dabaghian R, Ambrose HE, Gill ON. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009;338:1316. [Ref.ID 85943]
43.Tiene citas relacionadas Cita con resumen
Pocchiari M. Prevalence of variant CJD in the UK. BMJ 2009;338:1281-2. [Ref.ID 85940]
44. Cita con resumen
Mcque K. Genentech withdraws Raptiva in the US. Scrip 2009;3441:1,4. [Ref.ID 85672]
45. Cita con resumen
Rizzetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, Padovani A. Loss of sight and sound. Could it be the hip?. Lancet 2009;373:1052. [Ref.ID 85510]
46. Cita con resumen
Anónimo. US issues warning on chronic use of metoclopramide. BMJ 2009;338:562. [Ref.ID 85411]
47. Cita con resumen
Shah S. Genentech's Q5 profit soars but EPS guidance falls short. Scrip 2009;3430:9. [Ref.ID 85172]
48. Cita con resumen
Guha M. Second case of PML seen with psoriasis drug Raptiva. Scrip 2008;3417/18:27. [Ref.ID 84623]
49.
Rothwell PM. Atherothrombosis and ischaemic stroke. BMJ 2007;334:379-80. [Ref.ID 79353]
50. Cita con resumen
Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-66. [Ref.ID 75316]
51.Tiene citas relacionadas Cita con resumen
Colchester ACF, Colchester NTH. The origin of bovine spongiform encephalopathy: the human prion disease hypothesis. Lancet 2005;366:856-61. [Ref.ID 74773]
52.Tiene citas relacionadas Cita con resumen
Shankar SK, Satishchandra P. Did BSE in the UK originate from the Indian subcontinent?. Lancet 2005;366:790-1. [Ref.ID 74763]
53. Cita con resumen
Bornebroek M, Kumar-Singh S. A novel drug target in Alzheimer's disease. Lancet 2004;364:1738-9. [Ref.ID 71892]
54. Cita con resumen
England JD, Asbury AK. Peripheral neuropathy. Lancet 2004;363:2151-61. [Ref.ID 70566]
55. Cita con resumen
Priola S A, Vorberg I. Identification of possible animal origins of prion disease in human beings. Lancet 2004;363:2013-4. [Ref.ID 70479]
56. Cita con resumen
Anónimo. Zyprexa study raises cost-benefit question. Scrip 2003;2906:24. [Ref.ID 68231]
57. Cita con resumen
Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence?. Lancet 2003;362:1659-66. [Ref.ID 68173]
58. Cita con resumen
Turner-Stokes L. Poststroke depression: getting the full picture. Lancet 2002;361:1757-8. [Ref.ID 66077]
59. Cita con resumen
Bradbury J. Therapy found for Parkinson's disease dyskinesia. Lancet 2003;361:1712. [Ref.ID 66061]
60. Cita con resumen
Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003;361:1642-4. [Ref.ID 66030]
Seleccionar todas
 
<< anterior 41 a 60 de 343 siguiente >>